Book a Call Apply Now

Sam Gandy

Sam Gandy

Sam is a PhD ecologist, independent researcher and science communicator. His work in the psychedelic field includes a past role as a scientific assistant to the director of the Beckley Foundation (and a current role as a scientific researcher), a scientific editor for Beckley Retreats, a senior science writer for Wavepaths, and a research assistant and ecopsychology coordinator with the Synthesis Institute. 
 
Sam Gandy_1
 
His work as an independent researcher has involved collaborations with a range of academics and institutes, his research spanning the transformative potential of altered states of consciousness, with a primary research interest in the capacity of psychedelic substances to influence human relationships with nature.

“High-functioning depression” is a commonly used phrase for when someone appears competent, successful, and engaged in daily life while privately...

Read More

Up to 20% of adults across the globe live with some form of chronic pain disorder, which can have a huge impact on well-being and quality of life.

Read More

Research shows that psilocybin therapy may offer a new approach to addressing grief and its related mental health symptoms.

Read More

A woman in her 80s with Alzheimer’s disease regained the ability to speak after consuming psilocybin, say researchers Lago et al. in a case report...

Read More

Don’t kid yourself - when it comes to psilocybin retreats and red flags, reading Yelp reviews isn’t enough.

Read More

Too many people think alcoholism means just liking booze a little too much. For some, that definitely contributes.

Read More

Psychedelics are having a moment. LSD, ketamine, and especially psilocybin are receiving deserved clinical attention as more than a recreational...

Read More

The numbers behind post-traumatic stress disorder, or PTSD, are more shocking than you know. The World Health Organization (WHO) estimates that about...

Read More

Researchers at the UC Davis Institute for Psychedelics & Neurotherapeutics are working on a new class of psychedelic drug: one that doesn’t cause you...

Read More